CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide, Inc., a privately held medical device company in Cambridge, Massachusetts, today announced that it has appointed industry veteran Scott Flora as its President & CEO and member of the Board of Directors. Mr. Flora brings to OmniGuide more than 20 years of experience building and managing successful medical device businesses. He most recently served as Global Business Unit President of Surgical Devices at Covidien (NYSE:COV), where he was responsible for Covidien’s largest division.
Mr. Flora will begin his role at OmniGuide on November 1, 2011 and Yoel Fink, Ph.D., OmniGuide’s Founder, will serve as Chairman of the OmniGuide Board of Directors following his recent promotion to Director of the Research Laboratory of Electronics at M.I.T.
"We are excited to have Scott take on this leadership role at an important juncture in our company’s commercial expansion. Scott brings extensive industry experience and expertise to OmniGuide that is highly relevant to our surgical products business. As we continue to advance our high precision surgical cutting and ablation tools, Scott’s history of delivering growth while ensuring a high quality patient and provider experience will be exactly the skill set we need to further enhance our market position," said Yoel Fink, Ph.D., Founder and Chairman of the OmniGuide Board of Directors.
From 2006 through 2011, Mr. Flora led the surgical products division at Covidien, a global leader in healthcare products and one of the largest commercial organizations in the medical device industry. Mr. Flora was a strong contributor to Covidien’s overall growth through innovative sales and marketing initiatives, new product development and strategic mergers and acquisitions. Prior to Covidien, Mr. Flora spent fifteen years at Smith & Nephew, most recently serving as President & General Manager of the Orthopedics Reconstruction business. Mr. Flora earned his B.S. in Marketing from Millikin University. He has also completed executive programs at INSEAD, Wharton and Yale. "OmniGuide is uniquely positioned with a proprietary platform technology that can significantly enhance the health of patients while delivering both quality and cost-effectiveness to providers and payers. I believe that there is a tremendous opportunity to advance the business and build substantial value by using the OmniGuide platform to bring improved solutions to the operating room," said Mr. Flora. "I look forward to working closely with OmniGuide’s customers and employee base to help take the Company to the next level."
About OmniGuide.
OmniGuide, Inc. is the worldwide leader in the development and marketing of precision flexible optical scalpels for minimally invasive surgery. OmniGuide’s products are sold under the BeamPath® brand and are clinically targeted for superior clinical outcomes in specific surgical procedures. OmniGuide also offers a line of fiber-enabled, portable, low-cost CO2 lasers for use in the operating room. The Company designs and manufactures its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber technology exclusively licensed from M.I.T. The Company distributes its products in the U.S. through a direct sales force and in Europe through distribution partners. OmniGuide is committed to developing products that improve and expand surgical treatment options, enhance clinical outcomes, and reduce treatment complexity and cost.
Additional information about OmniGuide may be found at www.omni-guide.com.